+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Deep Brain Stimulation Devices Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5206441
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Deep Brain Stimulation Devices Market grew from USD 1.76 billion in 2024 to USD 2.04 billion in 2025. It is expected to continue growing at a CAGR of 15.10%, reaching USD 4.11 billion by 2030.

Deep brain stimulation (DBS) has revolutionized the treatment of a spectrum of neurological disorders by offering targeted electrical modulation of brain circuits. Originally designed to alleviate motor symptoms in movement disorders, DBS has rapidly expanded its therapeutic reach, addressing complex conditions such as chronic pain, psychiatric disorders, and epilepsy. Underpinned by advances in device engineering, surgical precision, and neurophysiological mapping, modern DBS systems integrate miniaturized implantable pulse generators with sophisticated leads capable of delivering current with unprecedented spatial accuracy.

This introductory overview examines the critical factors driving the evolution of the DBS device market. From the innovations in implant materials that enhance biocompatibility to the emergence of closed-loop programming that adapts stimulation in real time, stakeholders now navigate a dynamic landscape defined by technological convergence. As demand increases for patient-specific therapies, the industry must balance regulatory requirements, cost pressures, and the imperative for robust clinical evidence. This section sets the stage by highlighting the key market drivers, the expanding range of indications, and the collaborative ecosystem of device manufacturers, healthcare providers, and research institutions refining neuromodulation strategies for the next generation of DBS therapies.

Transformative Shifts Shaping the Deep Brain Stimulation Market

The DBS device market is undergoing transformative shifts that redefine how therapies are designed, delivered, and optimized. Technological integration now unites advanced imaging, real-time neural sensing, and artificial intelligence-driven algorithms to enable closed-loop systems that automatically adjust stimulation parameters based on neural feedback. Simultaneously, miniaturization trends have reduced device footprints, supporting more comfortable implants and longer battery life, while wireless integration offers remote programming capabilities that enhance patient convenience and clinician oversight.

Beyond hardware, evolving clinical protocols are broadening the range of approved indications. Initially focused on Parkinson’s disease and essential tremor, DBS now addresses chronic pain, dystonia, obsessive-compulsive disorder, and major depressive disorder via tailored electrode configurations and adaptive stimulation patterns. Meanwhile, novel surgical techniques such as multi-segment implantation facilitate more precise targeting of subcortical structures, improving therapeutic outcomes and reducing adverse effects.

These shifts reflect an industry pivot toward personalized neuromodulation, where data-driven insights inform device selection, electrode placement, and stimulation strategies. As competition intensifies, system interoperability, cybersecurity resilience, and health economics considerations will further influence market trajectories.

Cumulative Impact of United States Tariffs Effective in 2025

With the introduction of new tariffs on imported medical device components in 2025, manufacturers of DBS systems face mounting cost pressures. Components such as implantable pulse generators, leads, specialized polymers, and electronic modules are often sourced globally; the added duty rates on these critical inputs have the potential to inflate production costs significantly. Consequently, supply chain strategies are shifting toward regional diversification, with industry players evaluating near-shoring of assembly operations and forging partnerships with domestic suppliers to mitigate tariff exposure.

These changes impact pricing negotiations with payers and hospitals, where reimbursement frameworks are already under scrutiny for high-cost technologies. To sustain profitability, firms may explore cost-containment measures including lean manufacturing techniques, value-based contracting, and bundled service offerings that align device costs with clinical outcomes. In parallel, regulatory compliance requirements remain stringent, requiring that any alterations to component sourcing or manufacturing processes maintain quality standards and obtain requisite clearances.

Looking ahead, the cumulative effect of 2025 tariffs underscores the importance of agile supply chains and proactive stakeholder engagement. By transparently communicating tariff-induced cost shifts and collaborating on innovative procurement models, device companies can safeguard market access while preserving investment in R&D and next-generation therapy development.

Key Segmentation Insights Driving Market Differentiation

Insights drawn from detailed segmentation reveal nuanced market dynamics across multiple dimensions. Based on product type, the market encompasses accessories, implantable pulse generators, lead extensions, and leads, each demanding specific development and regulatory strategies to address unique performance and safety requirements. When considering application, technologies are tailored for chronic pain-including cancer-related and neuropathic pain-depression broken down into bipolar and major depressive disorders, dystonia, epilepsy, essential tremor, obsessive-compulsive disorder, and Parkinson’s disease.

End-user environments span ambulatory surgical centers, hospitals, neurology clinics, and research institutes, with academic institutions and government research centers playing a key role in early-stage innovation. Material selection impacts device longevity and patient comfort, ranging from metals and silicones to thermoplastic elastomers and polyurethanes. Patient age profiles influence system design, with pediatric offerings calibrated for adolescents, children, and infants and toddlers, alongside adult configurations.

Power source preferences separate primary cell battery-powered systems from rechargeable solutions, affecting device size and maintenance protocols. Signal type segmentation differentiates constant current from constant voltage approaches, while connectivity frameworks extend from wired control to advanced wireless integration. Programming architectures distinguish closed-loop adaptive systems from open-loop platforms, and procedural choices encompass multi-segment versus single-segment implantation. Finally, charging technologies span conductive and inductive methods, enabling diverse patient experiences and clinical workflows.

Strategic Regional Dynamics and Growth Patterns

Regional analysis highlights distinct growth drivers and competitive landscapes across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, robust research funding and a well-established reimbursement infrastructure underpin rapid adoption of next-generation DBS systems, with the United States sustaining leadership through strategic collaborations between device manufacturers and leading academic medical centers.

In Europe, Middle East & Africa, regulatory harmonization efforts and health technology assessments shape market entry strategies; strong government support in select European countries accelerates diffusion of novel implantable technologies, while Middle East markets show rising demand fueled by growing awareness of neuromodulation therapies. In Africa, limited infrastructure poses challenges, yet pilot programs in academic centers indicate expanding interest.

Asia-Pacific presents a dynamic environment characterized by increasing healthcare expenditure, burgeoning middle-class demand, and evolving regulatory frameworks in China, Japan, India, and Southeast Asia. Local manufacturing initiatives and licensing partnerships have emerged to address cost sensitivities, while regional research institutes spearhead clinical trials that explore DBS applications in psychiatric and pediatric populations. Across all regions, cross-border collaborations and digital health integration remain pivotal to sustaining market momentum.

Competitive Landscape and Leading Industry Players

The competitive landscape features a mix of global medtech giants, simulation and software specialists, and innovative neuromodulation pioneers. Leading manufacturers such as Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, and St. Jude Medical, Inc. drive market expansion through comprehensive product portfolios and extensive clinical collaborations. These firms invest heavily in iterative hardware refinement and explore adjacent indications to diversify their neuromodulation pipelines.

Supporting technology providers like ANSYS, Inc., Dassault Systèmes SE, General Electric Co., and Siemens AG contribute advanced simulation tools, imaging platforms, and data analytics that optimize device design, surgical planning, and post-implantation programming. Specialized players including Aleva Neurotherapeutics SA, Biowave, Comphya SA, and Nexstim focus on niche applications and closed-loop architectures, offering point solutions that enhance therapy personalization.

Engineering and mapping innovators such as Bentley Systems, Inc., Renishaw PLC, and Trimble Inc. deliver precision navigation and 3D visualization systems that improve electrode placement accuracy and reduce OR times. These collaborations between hardware, software, and services providers underscore the importance of integrated ecosystems in advancing DBS effectiveness and patient outcomes.

Actionable Recommendations for Industry Leaders

To thrive in this evolving environment, industry leaders should pursue a multilateral strategy that emphasizes collaboration, agility, and patient-centric innovation. First, establishing co-development partnerships with academic and clinical research centers will accelerate evidence generation for new indications. Second, diversifying supply chains through regionalized manufacturing hubs and alternative sourcing agreements can buffer the impact of tariffs and minimize disruptions.

Third, investing in digital platforms that facilitate remote programming, real-time monitoring, and predictive maintenance will enhance care continuity and differentiate service offerings. Fourth, engaging proactively with reimbursement agencies and health technology assessment bodies is critical to securing favorable coverage policies and demonstrating the value of advanced DBS interventions. Fifth, developing modular platforms that accommodate multiple power, connectivity, and charging options can address diverse patient needs and streamline product portfolios.

By integrating these initiatives, organizations can build resilient operations, reinforce clinical credibility, and deliver personalized neuromodulation therapies that meet rising demand across global markets.

Conclusion: Navigating the Future of Deep Brain Stimulation

Deep brain stimulation stands at the forefront of neuromodulation, offering transformative potential for patients with intractable neurological and psychiatric disorders. Technological advances-from adaptive closed-loop systems to wireless integration-are reshaping how therapies are delivered and managed, while evolving clinical protocols expand the scope of approved indications. Simultaneously, external factors such as new tariffs, regional regulatory landscapes, and competitive pressures necessitate agile strategies in supply chain management, stakeholder engagement, and reimbursement negotiation.

Market participants who leverage detailed segmentation insights will design more effective product portfolios, tailor solutions to specific end-user environments, and optimize patient outcomes across age and indication spectra. Regional dynamics underscore the importance of localized partnerships and regulatory alignment to accelerate market entry and sustain adoption. Meanwhile, integrated ecosystems combining hardware, software, and services will redefine competitive advantage, driving value-based care models that align clinical efficacy with economic sustainability.

As the field progresses, continuous collaboration between device manufacturers, healthcare providers, and payers will be essential to unlocking the full promise of deep brain stimulation and establishing new standards of personalized neuromodulation.

Market Segmentation & Coverage

This research report categorizes the Deep Brain Stimulation Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Accessories
  • Implantable Pulse Generators
  • Lead Extensions
  • Leads
  • Chronic Pain
    • Cancer Pain
    • Neuropathic Pain
  • Depression
    • Bipolar Depression
    • Major Depressive Disorder
  • Dystonia
  • Epilepsy
  • Essential Tremor
  • Obsessive-Compulsive Disorder
  • Parkinson's Disease
  • Ambulatory Surgical Centers
  • Hospitals
  • Neurology Clinics
  • Research Institutes
    • Academic Institutions
    • Government Research Centers
  • Metal
  • Polyethylene
  • Polyurethane
  • Silicone
  • Thermoplastic Elastomer
  • Adults
  • Pediatric
    • Adolescents
    • Children
    • Infants and Toddlers
  • Primary Cell Battery Powered
  • Rechargeable Battery Powered
  • Constant Current
  • Constant Voltage
  • Wired Control
  • Wireless Integration
  • Closed-Loop
  • Open-Loop
  • Multi-Segment Implantation
  • Single-Segment Implantation
  • Conductive Charging
  • Inductive Charging

This research report categorizes the Deep Brain Stimulation Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Deep Brain Stimulation Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • ANSYS, Inc.
  • Bentley Systems, Inc.
  • Biowave
  • Boston Scientific Corporation
  • Comphya SA
  • Dassault Systèmes SE
  • General Electric Co.
  • Medtronic PLC
  • Nexstim
  • Renishaw PLC
  • Siemens AG
  • St. Jude Medical, Inc.
  • Trimble Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Deep Brain Stimulation Devices Market, by Product Type
8.1. Introduction
8.2. Accessories
8.3. Implantable Pulse Generators
8.4. Lead Extensions
8.5. Leads
9. Deep Brain Stimulation Devices Market, by Application
9.1. Introduction
9.2. Chronic Pain
9.2.1. Cancer Pain
9.2.2. Neuropathic Pain
9.3. Depression
9.3.1. Bipolar Depression
9.3.2. Major Depressive Disorder
9.4. Dystonia
9.5. Epilepsy
9.6. Essential Tremor
9.7. Obsessive-Compulsive Disorder
9.8. Parkinson's Disease
10. Deep Brain Stimulation Devices Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Neurology Clinics
10.5. Research Institutes
10.5.1. Academic Institutions
10.5.2. Government Research Centers
11. Deep Brain Stimulation Devices Market, by Material
11.1. Introduction
11.2. Metal
11.3. Polyethylene
11.4. Polyurethane
11.5. Silicone
11.6. Thermoplastic Elastomer
12. Deep Brain Stimulation Devices Market, by Patient Age
12.1. Introduction
12.2. Adults
12.3. Pediatric
12.3.1. Adolescents
12.3.2. Children
12.3.3. Infants and Toddlers
13. Deep Brain Stimulation Devices Market, by Power Source
13.1. Introduction
13.2. Primary Cell Battery Powered
13.3. Rechargeable Battery Powered
14. Deep Brain Stimulation Devices Market, by Signal Type
14.1. Introduction
14.2. Constant Current
14.3. Constant Voltage
15. Deep Brain Stimulation Devices Market, by Connectivity
15.1. Introduction
15.2. Wired Control
15.3. Wireless Integration
16. Deep Brain Stimulation Devices Market, by Programming
16.1. Introduction
16.2. Closed-Loop
16.3. Open-Loop
17. Deep Brain Stimulation Devices Market, by Procedure Type
17.1. Introduction
17.2. Multi-Segment Implantation
17.3. Single-Segment Implantation
18. Deep Brain Stimulation Devices Market, by Charging Technology
18.1. Introduction
18.2. Conductive Charging
18.3. Inductive Charging
19. Americas Deep Brain Stimulation Devices Market
19.1. Introduction
19.2. Argentina
19.3. Brazil
19.4. Canada
19.5. Mexico
19.6. United States
20. Asia-Pacific Deep Brain Stimulation Devices Market
20.1. Introduction
20.2. Australia
20.3. China
20.4. India
20.5. Indonesia
20.6. Japan
20.7. Malaysia
20.8. Philippines
20.9. Singapore
20.10. South Korea
20.11. Taiwan
20.12. Thailand
20.13. Vietnam
21. Europe, Middle East & Africa Deep Brain Stimulation Devices Market
21.1. Introduction
21.2. Denmark
21.3. Egypt
21.4. Finland
21.5. France
21.6. Germany
21.7. Israel
21.8. Italy
21.9. Netherlands
21.10. Nigeria
21.11. Norway
21.12. Poland
21.13. Qatar
21.14. Russia
21.15. Saudi Arabia
21.16. South Africa
21.17. Spain
21.18. Sweden
21.19. Switzerland
21.20. Turkey
21.21. United Arab Emirates
21.22. United Kingdom
22. Competitive Landscape
22.1. Market Share Analysis, 2024
22.2. FPNV Positioning Matrix, 2024
22.3. Competitive Analysis
22.3.1. Abbott Laboratories
22.3.2. Aleva Neurotherapeutics SA
22.3.3. ANSYS, Inc.
22.3.4. Bentley Systems, Inc.
22.3.5. Biowave
22.3.6. Boston Scientific Corporation
22.3.7. Comphya SA
22.3.8. Dassault Systèmes SE
22.3.9. General Electric Co.
22.3.10. Medtronic PLC
22.3.11. Nexstim
22.3.12. Renishaw PLC
22.3.13. Siemens AG
22.3.14. St. Jude Medical, Inc.
22.3.15. Trimble Inc.
23. ResearchAI
24. ResearchStatistics
25. ResearchContacts
26. ResearchArticles
27. Appendix
List of Figures
FIGURE 1. DEEP BRAIN STIMULATION DEVICES MARKET MULTI-CURRENCY
FIGURE 2. DEEP BRAIN STIMULATION DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. DEEP BRAIN STIMULATION DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 26. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 28. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 32. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. DEEP BRAIN STIMULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 38. DEEP BRAIN STIMULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DEEP BRAIN STIMULATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEAD EXTENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BIPOLAR DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY INFANTS AND TODDLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRIMARY CELL BATTERY POWERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RECHARGEABLE BATTERY POWERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONSTANT CURRENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONSTANT VOLTAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WIRED CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WIRELESS INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CLOSED-LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY OPEN-LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MULTI-SEGMENT IMPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SINGLE-SEGMENT IMPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONDUCTIVE CHARGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY INDUCTIVE CHARGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 113. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 114. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 116. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 117. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 118. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 119. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 120. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 121. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 122. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 123. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 124. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 128. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 129. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 132. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 134. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 137. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 138. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 139. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 190. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 191. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 193. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 194. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 195. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 196. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 197. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 199. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 200. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 201. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 205. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 206. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 208. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 209. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 210. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 211. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 212. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 213. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 214. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 215. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 235. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 236. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 238. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 239. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 240. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 241. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 242. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 243. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 244. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 245. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 246. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PATIENT AGE, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY SIGNAL TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMING, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHARGING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, 2

Companies Mentioned

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • ANSYS, Inc.
  • Bentley Systems, Inc.
  • Biowave
  • Boston Scientific Corporation
  • Comphya SA
  • Dassault Systèmes SE
  • General Electric Co.
  • Medtronic PLC
  • Nexstim
  • Renishaw PLC
  • Siemens AG
  • St. Jude Medical, Inc.
  • Trimble Inc.

Methodology

Loading
LOADING...